Objective: To study the relation of age and clinicopathologic pattern to the aggressiveness of thyroid cancer cases and the treatment results of patients from western region of Saudi Arabia with differentiated thyroid carcinoma referred for treatment in King Abdulaziz Hospital and Oncology Center, Jeddah, Saudi Arabia. Methods: Retrospective review of 174 patients with differentiated thyroid carcinoma and analysis of the clinicopathologic characteristics, age correlation to different risk factors, treatment protocol and results were performed. Results: Analysis of the clinicopathologic pattern showed no statistically significant difference between patients in the different age groups except for extrathyroid extension and lymph node involvement. Patients older than 45 years had a statistically significant lower incidence of nodal involvement and a higher rate of extrathyroid extension (<0.02). In this study, we used a high dose method (Radioiodine-131 dose 75 - 100 mCi) for thyroid remnant ablation after thyroidectomy (total or near total) in 134 patients. An Iodine - 131 dose of 200 mCi was used in 8 patients with distant metastases. In 24 patients with radioiodine-avid cervical lymph nodes and six patients with a gross residual tumor, an Iodine - 131 dose of 150 mCi was used. For the whole study group, the 5-year overall survival and disease-free survival were 96% and 88%. Conclusion: Despite the fact that differentiated thyroid carcinoma is among the most curable cancer some patients are still at high risk for recurrent and increased mortality .
Rahbari, R., Zhang, L. and Kebebew, E. (2010) Thyroid Cancer Gender Disparity. Future Oncology, 6, 1771-1779. https://doi.org/10.2217/fon.10.127
Brose, M.S., Worden, F.P., Newboid, K.L., Guo, M. and Hurria, A. (2017) Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SLECT Trial. Journal of Clinical Oncology, 35, 2692-2699. https://doi.org/10.1200/JCO.2016.71.6472
Hussain, F., Iqbal, S., Mehmood, A., Bazarbashi, S., ElHassan, T. and Chaudhri, N. (2013) Incidence of Thyroid Cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematology/Oncology and Stem Cell Therapy, 6, 58-64. https://doi.org/10.1016/j.hemonc.2013.05.004
Schneider, D.F. and Chen, H. (2013) New Developments in the Diagnosis and Treatment of Thyroid Cancer. CA: A Cancer Journal for Clinicians, 63, 373-394.
Zhang, W., Jiao, D., Liu, B. and Sun, S. (2016) Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy. Medical Science Monitor, 22, 1274-1279. https://doi.org/10.12659/MSM.895564
Doi, S.A.R., Woodhouse, N.J., Thalib, L. and Onitilo, A. (2007) Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited. Clinical Medicine & Research, 5, 87-90. https://doi.org/10.3121/cmr.2007.763
Fraker, D.L., Skarulis, M. and Livolsi, V. (1997) Thyroid Tumors. In: De Vita Jr., V.T., Hellman, S. and Rosenberg, S.A., Eds., Cancer: Principles and Practice of Oncology, Lippincott-Raven, Philadelphia, 1629-1652.
Tubiana, M., Haddad, E., Schlumberger, M., Hill, C., Rougier, P. and Sarrazin, D. (1985) External Radiotherapy in Thyroid Cancers. Cancer, 55, 2062-2071. https://doi.org/10.1002/1097-0142(19850501)55:9+ 3.0.CO;2-O
Ito, Y., Miyauchi, A., Kihara, M., Fukushima, M., Higashiyama, T. and Miya, A. (2018) Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients. World Journal of Surgery, 42, 615-622. https://doi.org/10.1007/s00268-018-4479-z
Su, D.H., Chang, S.H. and Chang, T.C. (2015) The Impact of Locoregional Recurrences and Distant Metastases on the Survival of Patients with Papillary Thyroid Carcinoma. Clinical Endocrinology, 82, 286-294. https://doi.org/10.1111/cen.12511
Gaissert, H.A., Honings, J., Grillo, H.C., Donahue, D.M., Wain, J.C., Wright, C.D. and Mathisen, D.J. (2007) Segmental Laryngotracheal and Tracheal Resection for Invasive Thyroid Carcinoma. The Annals of Thoracic Surgery, 83, 1952-1959. https://doi.org/10.1016/j.athoracsur.2007.01.056
Mattavelli, F., Bombardieri, E., Collini, P., et al. (2007) Role of Surgery in Treatment of Advanced Differentiated Thyroid Carcinomas. Acta Otorhinolaryngologica Italica, 27, 62-67.
Mazzaferri, E.L. and Jhiang, S.M. (1994) Long-Term Impact of Initial Surgical and Medical Therapy on Papillary and Follicular Thyroid Cancer. American Journal of Medicine, 97, 418-428. https://doi.org/10.1016/0002-9343(94)90321-2
Mazzaferri, E.L. and Kloos, R.T. (2001) Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 86, 1447-1463.
Indrasena, B.S.H. (2017) Use of Thyroglobulin as a Tumour Marker. World Journal of Biological Chemistry, 8, 81-85. https://doi.org/10.4331/wjbc.v8.i1.81
Deandrea, M., Ragazzoni, F., Motta, M., Torchio, B., Mormile, A., Garino, F., et al. (2010) Diagnostic Value of a Cytomorphological Subclassification of Follicular Patterned Thyroid Lesions: A Study of 927 Consecutive Cases with Histological Correlation. Thyroid, 20, 1077-1083. https://doi.org/10.1089/thy.2010.0015
Cunnigham, M.P., Duda, R.B., Recant, W., Chmeil, S.J.S., Sylvester, J. and Fremgen, A. (1990) Survival Discreminants for Differentiated Thyroid Cancer. The American Journal of Surgery, 160, 344-351.
McHenry, C.R., Rosen, I.B. and Walfish, P.G. (1991) Prospective Management of Nodal Metastases in Differentiated Thyroid Cancer. The American Journal of Surgery, 162, 353-356.
Akslen, L.A., Haldorsen, T., Thoresen, S.O. and Glattre, E. (1991) Survival and Causes of Death in Thyroid Cancer: A Population-Based Study of 2479 Cases from Norway. Cancer, 51, 1234-1241.
Billan, S. and Charas, T. (2016) External Beam Radiation in Differentiated Thyroid Carcinoma. Rambam Maimonides Medical Journal, 7, e0008. https://doi.org/10.5041/RMMJ.10235
Brierley, J.D. (2011) Update on External Beam Radiation Therapy in Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 96, 2289-2295.
Lerch, H., Schober, O., Kuwert, T. and Saur, H.B. (1997) Survival of Differentiated Thyroid Carcinoma Studied in 500 Patients. Journal of Clinical Oncology, 15, 2067-2075. https://doi.org/10.1200/JCO.1997.15.5.2067
Ito, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., et al. (2006) Prognostic Significance of Extrathyroid Extension of Papillary Thyroid Carcinoma: Massive but Not Minimal Extension Affects the Relapse-Free Survival. World Journal of Surgery, 30, 780-786. https://doi.org/10.1007/s00268-005-0270-z
Sebastian, S.O., Gonzalez, J.M., Paricio, P.P., Perez, J.S., Flores, D.P., Madrona, A.P., Romero, P.R. and Tebar, F.J. (2000) Papillary Thyroid Carcinoma Prognostic Index for Survival Including the Histological Variety. Archives of Surgery, 135, 272-277.
Shi, R.-L., Qu, N., Yang, S.-W., Ma, B., Lu, Z.-W., Wen, D., et al. (2016) Tumor Size Interpretation for Predicting Cervical Lymph Node Metastasis Using a Differentiated Thyroid Cancer Risk Model. OncoTargets and Therapy, 9, 5015-5022. https://doi.org/10.2147/OTT.S107187
Nie, X.L., Tan, Z., Ge, M.H., Jiang, L.H., Wang, J.F. and Zheng, C.M. (2016) Risk Factors Analyses for Lateral Lymph Node Metastases in Papillary Thyroid Carcinomas: A Retrospective Study of 356 Patients. Archives of Endocrinology and Metabolism, 60, 492-499.
Tsuchiya, A., Suzuki, S., Kanno, M., Kikuchi, Y., Ando, Y. and Abe, R. (1995) Prognostic Factors Associated with Differentiated Thyroid Cancer. Surgery Today, 25, 778-782. https://doi.org/10.1007/BF00311452
Coburn and Wanebo (1995) Age Correlates with Increased Frequency of High Risk Factors in Elderly Patients with Thyroid Cancer. American Journal of Surgery, 170, 471-475.
He, L.-Y., Wang, W.-W., Ibrahima, B.A., Han, S., Li, Z., Cai, Z., et al. (2016) The Prognostic Value of Regional Lymph Node Metastases in Patients of Guangdong Province, China with Differentiated Thyroid Cancer. Medicine, 95, e5034. https://doi.org/10.1097/MD.0000000000005034
Frankenthaler, R.A., Sellin, R.V., Cangir, A. and Goepfert, H. (1990) Lymph Node Metastasis from Papillary-Follicular Thyroid Carcinoma in Young Patients. The American Journal of Surgery, 160, 341-343.
Shinto, A.S., Kamaleshwaran, K.K., Shibu, D.K., Vyshak, K. and Antony, J. (2013) Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number? World Journal of Nuclear Medicine, 12, 61-64. https://doi.org/10.4103/1450-1147.136694
Cha, J.T., Hwang, S.H., Jo, K., Jeong, Y.H., Jeong, H., et al. (2015) Analysis of Ablation Failure in High Dose I-131 Ablation. Journal of Nuclear Medicine, 56, 1657.
Mohammadi, H. and Saghari, M. (1997) Hospital Discharge Policy in Thyroid Cancer Patients Treated with 131I: The Effect of Changing from Fixed Time to Exposure Rate Threshold. Health Physics, 72, 476-480.
Pineda, J.D., Lee, T., Ain, K., Reynolds, J.C. and Robbins, J. (1995) Iodine-131 Therapy for Thyroid Cancer Patients with Elevated Thyroglobulin and Negative Diagnostic Scan. The Journal of Clinical Endocrinology & Metabolism, 80, 1488-1492.